Allopurinol
- Product NDC
- 70934-681
- 11-digit product format
- 709340681
- Labeler code
- 70934
- Product ID
- 70934-681_f14eeed0-5577-6baf-e053-2995a90a6f28
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Allopurinol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA071450
- Marketing category
- ANDA
- Marketing start
- 2020-05-05
- Marketing end
- 2023-12-31
- Substance
- ALLOPURINOL
- Active strength
- 300 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-681-30 | 70934068130 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-681-30) | 30 tablet | 2021-03-12 | 0000-00-00 | No | No | Current |
| 70934-681-90 | 70934068190 | 90 TABLET in 1 BOTTLE, PLASTIC (70934-681-90) | 90 tablet | 2020-05-05 | 0000-00-00 | No | No | Current |